Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival

European Journal of Surgical Oncology

Volumn 32, Issue 10, 2006, Pages 1119-1124

  Yan, T D ^a   Chu, F ^a   Links, M ^b   Kam, P C ^b   Glenn, D ^b   Morris, D L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

Colorectal carcinoma; Cytoreductive surgery; Intraperitoneal chemotherapy; Peritoneal carcinomatosis; Peritoneal surface malignancy

Indexed keywords

ANTINEOPLASTIC AGENT; FLOXURIDINE; FOLINIC ACID; IRINOTECAN; MITOMYCIN C; OXALIPLATIN;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLON ADENOCARCINOMA; COLORECTAL CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOREDUCTIVE SURGERY; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HUMAN TISSUE; LENGTH OF STAY; MALE; METASTASIS POTENTIAL; MUCINOUS CARCINOMA; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PERITONEUM CANCER; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; MITOMYCIN; PERITONEAL NEOPLASMS; SURVIVAL RATE;

EID: 33751179010     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.06.007     Document Type: Article

References (37)

1. Jayne D.G., Fook S., Loi C., and Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89 (2002) 1545-1550
2. Chu D.Z., Lang N.P., Thompson C., Osteen P.K., and Westbrook K.C. Peritoneal carcinomatosis in nongynecologic malignancy: a prospective study of prognostic factors. Cancer 63 (1989) 364-367
3. Sadeghi B., Arvieux C., Glehen O., et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88 (2000) 58-63
4. Bloemendaal A.L., Verwaal V.J., van Ruth S., Boot H., and Zoetmulder F.A. Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: a prospective study. Eur J Surg Oncol 31 (2005) 1145-1151
5. Hurwitz H., Fehrenbacher L., Novotny W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350 (2004) 2335-2342
6. Hurwitz H.I., Fehrenbacher L., Hainsworth J.D., et al. Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer. J Clin Oncol 23 (2005) 3502-3508
7. Kabbinavar F.F., Schulz J., McCleod M., et al. Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial. J Clin Oncol 23 (2005) 3697-3705
8. Douillard J.Y., Cunningham D., Roth A.D., et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355 (2000) 1041-1047
9. Rothenberg M.L., Oza A.M., Bigelow R.H., et al. Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. J Clin Oncol 21 (2003) 2059-2069
10. Colucci G., Gebbin V., Paoletti G., et al. Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale. J Clin Oncol 23 (2005) 4866-4875
11. Sugarbaker P.H. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome. Lancet Oncol 7 (2006) 69-76
12. Sugarbaker P.H., Graves T., DeBruijn E.A., et al. Rationale for early postoperative intraperitoneal chemotherapy (EPIC) in patients with advanced gastrointestinal cancer. Cancer Res 50 (1990) 5790-5794
13. Look M., Chang D., and Sugarbaker P.H. Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum. Int J Gynecol Cancer 14 (2004) 35-41
14. Yan TD, Yoo D, Sugarbaker PH. Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol, in press. doi:10.1016/j.ejso.2006.05.009.
15. Verwaal V.J., van Ruth S., de Bree E., et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal origin. J Clin Oncol 21 (2003) 3737-3743
16. Glehen O., Kwiatkowski F., Sugarbaker P.H., et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22 (2004) 3284-3292
17. Carmignani C.P., Ortega-Perez G., and Sugarbaker P.H. The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer. Eur J Surg Oncol 30 (2004) 391-398
18. Glehen O., Cotte E., Schreiber V., Sayag-Beaujard A.C., Vignal J., and Gilly F.N. Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Br J Surg 91 (2004) 747-754
19. Elias D., Delperro J.R., Sideris L., et al. Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials. Ann Surg Oncol 11 (2004) 518-521
20. Elias D, Raynard B, Farkhondeh F, et al. Peritoneal carcinomatosis of colorectal origin: long-term results of intraperitoneal chemohyperthermia with oxaliplatin following complete cytoreductive surgery. Gastroenterol Clin Biol, in press.
21. Verwaal V.J., van Tinteren H., van Ruth S., and Zoetmulder F.A. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. Br J Surg 91 (2004) 739-746
22. Shen P., Hawksworth J., Lovato J., et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol 11 (2004) 178-186
23. Cavaliere F., Perri P., Di Filippo F., et al. Treatment of peritoneal carcinomatosis with intent to cure. J Surg Oncol 74 (2000) 41-44
24. Culliford IV A.T., Brooks A.D., Sharma S., et al. Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendiceal cancer. Ann Surg Oncol 8 (2001) 787-795
25. Pilati P., Mocellin S., Rossi C.R., et al. Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol 10 (2003) 508-513
26. Kecmanovic D.M., Pavlov M.J., Ceranic M.S., Sepetkovski A.V., Kovacevic P.A., and Stamenkovic A.B. Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy. Eur J Surg Oncol 31 (2005) 147-152
27. Mahteme H., Hansson J., Berglund A., et al. Imp roved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study. Br J Cancer 90 (2004) 403-407
28. Jacquet P., and Sugarbaker P.H. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res 15 (1996) 49-58
29. Sugarbaker P.H. Peritonectomy procedure. Ann Surg 221 (1995) 29-42
30. Sugarbaker P.H. Management of peritoneal surface malignancy using intraperitoneal chemotherapy and cytoreductive surgery: A manual for physicians and nurses. 3rd ed. (1995), the Ludmann Company, Grand Rapids, MI
31. Yan TD, Black D, Savady R, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma, J Clin Oncol, in press.
32. Nozoe T., Ani H., Nasu S., and Sugimachick K. Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol 75 (2000) 103-107
33. Papadopoulos V.N., Michalopoulos A., Netta S., et al. Prognostic significance of mucinous components in colorectal carcinoma. Tech Coloproctol 8 Suppl 1 (2004) S123-S125
34. Kanemuitsu Y., Kato T., Hirai T., et al. Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum 46 (2003) 160-167
35. Kang H., O'Connell J.B., Maggard M.A., Sack J., and Ko C.Y. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum 48 (2005) 1161-1168
36. Du W., Mah J.T., Lee J., Sankila R., Sakaranarayanan R., and Chia K.S. Incidence and survival of mucinous adenocarcinoma of the rectum: a population-based study from Asian country. Dis Colon Rectum 47 (2004) 78-85
37. Esquivel J, Sticca R, Sugarbaker PH, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Ann Surg Oncol, in press.